132 related articles for article (PubMed ID: 10929226)
1. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
Bockmühl U; Küchler I; Petersen I
HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
[TBL] [Abstract][Full Text] [Related]
2. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
Xie X; Clausen OP; Boysen M
Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
[TBL] [Abstract][Full Text] [Related]
3. [Deletion of chromosome 10q--a marker for metastasis of head-neck carcinomas?].
Bockmühl U; Schmidt S; Petersen S; Petersen I
Laryngorhinootologie; 2000 Feb; 79(2):81-5. PubMed ID: 10738714
[TBL] [Abstract][Full Text] [Related]
4. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in head-neck carcinomas].
Weber A; Tannapfel A
HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
[TBL] [Abstract][Full Text] [Related]
7. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma.
Hermsen M; Alonso Guervós M; Meijer G; van Diest P; Suárez Nieto C; Marcos CA; Sampedro A
Cell Oncol; 2005; 27(3):191-8. PubMed ID: 16037640
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
11. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
Bosch FX; Homann N; Conradt C; Dietz A; Erber R
HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
[No Abstract] [Full Text] [Related]
12. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
13. Variable genetic alterations and survival in head and neck cancer.
Gleich LL; Li YQ; Wang X; Stambrook PJ; Gluckman JL
Arch Otolaryngol Head Neck Surg; 1999 Sep; 125(9):949-52. PubMed ID: 10488977
[TBL] [Abstract][Full Text] [Related]
14. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation.
Ashman JN; Patmore HS; Condon LT; Cawkwell L; Stafford ND; Greenman J
Br J Cancer; 2003 Sep; 89(5):864-9. PubMed ID: 12942119
[TBL] [Abstract][Full Text] [Related]
16. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
17. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization.
Götte K; Tremmel SC; Popp S; Weber S; Hörmann K; Bartram CR; Jauch A
Adv Otorhinolaryngol; 2005; 62():38-48. PubMed ID: 15608416
[TBL] [Abstract][Full Text] [Related]
19. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
